Dr. Parvez S. Mantry, MD

Dr. Mantry practices at Methodist Medical Group in Dallas, Texas.

Dr. Mantry's NPI, 1770528697, was assigned on June 17, 2006. Dr. Mantry graduated from Lokmanya Tilak Municipal Medical College in 1995. Dr. Mantry's Texas license number on file is M9481.

Dr. Mantry's primary practice is Methodist Medical Group, at 3400 W Wheatland Rd, Dallas, TX 75237 in Dallas County. The practice phone is (214) 884-4700.

Dr. Mantry's primary practice is Methodist Medical Group in Dallas, Texas. Dr. Mantry is also affiliated with Methodist Dallas Medical Center. The medical group on file is Methodist Medical Group. Dmand AI also links Dr. Mantry to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mantry practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mantry's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mantry is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mantry's licenses on file in 3 states: Texas, Florida and New York.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Mantry treats.

CMS data shows 609 Medicare services from Dr. Mantry across 9 procedure codes in 2024, for 326 Medicare patients. Medicare paid $47,957 for them.

CMS counts 326 Medicare patients who saw Dr. Mantry in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mantry's median patient age at 66, with 51% women.

In 2024, Dr. Mantry wrote 2,310 Medicare Part D claims for 318 patients. 76% of them were for generic drugs. CMS names the drug for 2,028 of them, across 32 drugs with 11 or more claims each, at $2,277,877 in total drug cost. In 2023, CMS named 1,555 claims across 32 drugs.

Dr. Mantry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mantry as offering telehealth. CMS counts 73 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Mantry, more than 70% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 64 papers to Dr. Mantry, published from 2007 to 2025. 2015 was the busiest year, with 7. The most frequent topics are Antiviral Agents, Hepatitis C, Chronic and Liver Transplantation. Dr. Mantry has published most often in Clin Gastroenterol Hepatol. Dr. Mantry's most frequent co-authors are Razi M. Arifuddin, MD, Tarek I. Hassanein, MD and Adel Bozorgzadeh, MD.

Dmand AI links Dr. Mantry to 18 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Liver Diseases, Liver Cirrhosis, Biliary and Non-alcoholic Fatty Liver Disease. Intercept Pharmaceuticals sponsors the most, 4.

CMS Open Payments shows 1,641 general payments to Dr. Mantry from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Novo Nordisk Inc paid the most, $199,075.

Dr. Mantry graduated from Lokmanya Tilak Municipal Medical College in 1995.

Dr. Mantry is in network with 22 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.